CompletedPhase 2/3

Transfusion in Gastrointestinal Bleeding

United Kingdom936 participantsStarted 2012-09

Plain-language summary

Aim: To evaluate the feasibility and safety of a restrictive versus liberal red blood cell (RBC) transfusion policy in adult patients admitted with Acute Upper Gastrointestinal Bleeding (AUGIB) in order to inform the design of a definitive phase III randomised controlled trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 or over years presenting with AUGIB, defined by haematemesis or melaena. Exclusion Criteria: * Patients with whom the responsible clinician considers there is a need for immediate RBC transfusion prior to obtaining or regardless of the initial Hb result due to severity of bleeding. * Existing hospital in-patients who develop AUGIB.

What they're measuring

Adherence to the study protocol

Timeframe: up to 28 days

Trial details

NCT IDNCT02105532

SponsorDr Vipul Jairath

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2013-04

View on ClinicalTrials.gov More Gastrointestinal Hemorrhage trials